Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Integration of the basic, behavioral, and biomaterials sciences with the clinical curriculum

Autor: H Mohammed, WB Shreve, WB Clark th, WL Mealiea

Publikováno v: Journal of Dental Education. 44:76-79

An approach to effective integration of the basic, behavioral, and biomaterials sciences with the clinical curriculum is described. Teaching is accomplished by both scientists and clinicians on multidisciplinary teams. The instructional format is bas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::946d05c41c9a5f9cce876f6d4f593231
https://doi.org/10.1002/j.0022-0337.1980.44.2.tb01328.x

Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis

Autor: Wu Henry M, Cordeiro Soraia M, Harcourt Brian H, Carvalho MariadaGloriaS, Azevedo Jailton, Oliveira Tainara Q, Leite Mariela C, Salgado Katia, Reis Mitermayer G, Plikaytis Brian D, Clark Thomas A, Mayer Leonard W, Ko Albert I, Martin Stacey W, Reis Joice N

Publikováno v: BMC Infectious Diseases, Vol 13, Iss 1, p 26 (2013)

Abstract Background Although cerebrospinal fluid (CSF) culture is the diagnostic reference standard for bacterial meningitis, its sensitivity is limited, particularly when antibiotics were previously administered. CSF Gram staining and real-time PCR

Externí odkaz: https://doaj.org/article/a59d5f7c68604bfa9e2cdc2c360be05e

Glukonsäure

Autor: Bennet-Clark, Th. A.

Publikováno v: Fresenius' Journal of Analytical Chemistry; January 1936, Vol. 106 Issue: 1-2 p70-71, 2p

A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.

Autor: Fisher TS; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA. timothy.s.fisher@pfizer.com.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA. timothy.s.fisher@pfizer.com.; Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA. timothy.s.fisher@pfizer.com., Hooper AT; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Lucas J; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Clark TH; BioMedicine Design Pfizer Inc., Cambridge, MA, USA., Rohner AK; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Peano B; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Elliott MW; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Tsaparikos K; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Wang H; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Golas J; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Gavriil M; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA., Haddish-Berhane N; BioMedicine Design Pfizer Inc., Cambridge, MA, USA.; Johnson and Johnson Pharmaceutical Research and Development, Spring House, PA, USA., Tchistiakova L; BioMedicine Design Pfizer Inc., Cambridge, MA, USA., Gerber HP; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA.; Maverick Therapeutics, Brisbane, CA, USA., Root AR; BioMedicine Design Pfizer Inc., Cambridge, MA, USA., May C; Oncology Research and Development Pfizer Inc., La Jolla, CA, USA.; Oncology Research and Development Pfizer Inc., Pearl River, NY, USA.; Maverick Therapeutics, Brisbane, CA, USA.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Feb; Vol. 67 (2), pp. 247-259. Date of Electronic Publication: 2017 Oct 24.